Mutimodal Artificial Intelligence for Optimising Renal Tumour Management: Diagnosis, Surgery and Prognosis
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,100
- 试验地点
- 1
- 主要终点
- Assessing the performance of AI models by the "AUC" comprehensive assessment model
研究概览
简要总结
The goal of this observational study is to improve the management of people with renal tumour by multimodal artificial intelligence(AI). It will also measure the accuracy of the predictions from AI models. The main questions it aims to answer are:
- whether the AI module can accurately provide tumor-related information such as Benign or malignant, subtypes, grading, stage, etc. by learning from preoperative CT images.
- whether the AI module can help clinicians find out the most suitable surgical programme for people with renal tumor.
- whether the AI module can integrate CT images and pathology slides, offering supplementary prognostic information to improve postoperative survival.
Participants who complete a CT(usually Contrast-enhanced CT, CECT) examination and undergo radical or partial nephrectomy will carry out active surveillance and record postoperative survival data for 5 years.
详细描述
In this study, AI model will explore and clarify features in renal tumor CT images and pathological images that are difficult to detect manually, and then correlate them with clinical outcomes, thereby improving the diagnosis and treatment process for renal tumors. Firstly, the model can accurately distinguish renal tumor subtypes and predict stage, grade, and complexity so as to svoid misdiagnosis and assist clinicians in formulating treatment plans. Secondly, by learning from surgical videos, the model can provide additional information during surgerys, such as important anatomical landmarks, location of tumors. Finally, combining radiomics and pathomics, the model can differentiate between high-risk and low-risk patients after surgery, thus providing personalized prognostic guidance.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with renal tumor which can be treated by surgery;
- •Complete CECT within 30 days before surgery;
- •Patients who fully understand this study and sign the informed consent;
排除标准
- •Patients with any item missing from the baseline clinical and pathological information;
- •Patients who has already metastasized by the time the tumor is discovered;
- •Previous treatment in any form, including surgery, targeted therapy and immunotherapy;
结局指标
主要结局
Assessing the performance of AI models by the "AUC" comprehensive assessment model
时间窗: From enrollment to the end of 5-years' follow up
"AUC" refers to the area under the ROC (Receiver Operating Characteristic) curve, which indicates the performance of the model in predicting immunohistochemistry-related pathological information of prostate cancer after surgery, and the AUC ranges from 0-1, with the larger value indicating the better prediction effect.
次要结局
- Assessing the model's performance to predict participants' prognosis post-surgery by Kaplan-Meier Survival Analysis(From enrollment to the end of 5-years' follow up)
研究者
Shao Pengfei
chief physician
The First Affiliated Hospital with Nanjing Medical University